The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial to evaluate the epithelial-to-mesenchymal (EMT) inhibitor sotevtamab combined with docetaxel in patients with metastatic non-small cell lung cancer following failure of primary chemoimmunotherapy.
 
Normand Blais
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Janssen Oncology; Merck; Novartis; Pfizer; Roche Canada; Sanofi; Takeda
Research Funding - AstraZeneca (Inst)
 
Ghislain Cournoyer
No Relationships to Disclose
 
Jean-Luc Dionne
No Relationships to Disclose
 
Catherine Labbe
No Relationships to Disclose
 
Louis Gaboury
No Relationships to Disclose
 
Vincent Quoc-Huy Trinh
No Relationships to Disclose
 
Julia V. Burnier
No Relationships to Disclose
 
Alexandra Bartolomucci
No Relationships to Disclose
 
Elisabeth Viau
Employment - Alethia Biotherapeutics
 
Julie Laurin
Employment - Alethia Biotherapeutics
Stock and Other Ownership Interests - Alethia Biotherapeutics
 
Mario Filion
Employment - Alethia Biotherapeutics
Stock and Other Ownership Interests - Alethia Biotherapeutics
Consulting or Advisory Role - Iricor
 
Jacques Jolivet
Leadership - Starpax Medical
Consulting or Advisory Role - Alethia Biotherapeutics
 
Lauren Averett Byers
Honoraria - Clinical Care Options; UpToDate
Consulting or Advisory Role - Abbvie; Amgen; Arrowhead Pharmaceuticals; AstraZeneca; BeiGene; Chugai Pharma; Daiichi Sankyo; Genentech; Jazz Pharmaceuticals; Merck Sharp & Dohme Corp.; Puma Biotechnology
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jazz Pharmaceuticals (Inst)